Form 8-K · Current report
Dow Inc. 8-K, filed Jul 23, 2026
- Filed
- CIK
- 0001751788
- Accession no.
- 0001751788-26-000144
Summary
Dow Inc. reported second-quarter 2026 net sales of $12.1 billion, up 20% year-over-year, GAAP net income of $802 million and operating EPS of $1.44 compared with a year-ago loss, driven by higher prices and its Transform to Outperform self-help program. The company said it now expects roughly $200 million more in 2026 benefits from that program, lifting total in-year self-help benefits above $1.3 billion.
Key points
- Dow's second-quarter 2026 net sales rose 20% to $12.1 billion, with local price up 20% and volume down 1% year-over-year.
- GAAP net income was $802 million and operating EBIT was $1.6 billion, up $1.7 billion from a year earlier; operating EPS was $1.44 versus a year-ago loss of $0.42.
- Cash from continuing operations was $1.3 billion and shareholder returns totaled $253 million of dividends in the quarter.
- CEO Karen S. Carter said self-help initiatives delivered ahead of plan and that Dow now expects about $200 million more in 2026 benefits from Transform to Outperform, taking total in-year self-help benefits above $1.3 billion.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 23, 2026, Dow Inc. issued a press release, attached as Exhibit 99.1 and incorporated herein by reference, announcing results for the second quarter of 2026. The information contained in this report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of Section 18. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.